SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-17-016064
Filing Date
2017-08-07
Accepted
2017-08-07 17:09:02
Documents
4
Effectiveness Date
2017-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 - 2017 EVERGREEN AND NASDAQ atra-s8.htm S-8 118675
2 EX-5.1 atra-ex5_62.htm EX-5 15362
3 EX-23.2 atra-ex232_6.htm EX-23.2 2308
4 GRAPHIC g201708072100156222394.jpg GRAPHIC 28720
  Complete submission text file 0001564590-17-016064.txt   177103
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-219763 | Film No.: 171012299
SIC: 2836 Biological Products, (No Diagnostic Substances)